# How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-05 23:29 UTC · Category: Business · Sources: 6 · Current Velocity: 3.67

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Fortune | Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company—finding its next blockbuster drug is proving difficult | 2026-08-05 16:52 | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxPX3l6Wm42S0tJM2t0MXFFaFp4N2hRYXRucmJxTHY2ZFRwZmh3WWxOMllETThRdWU3TDRSNTMycVA0N1NuM1h5Nm4zTjdpN19IQWxCOE40blhieU1GcXRFYmx0U0I4TklXdDVFSWN1TTJMOVpDVENMTXpTdHptWlJKRkFCblpzVkNsUjBQY1ExUlNzQlFhbGtrV0l2dGxCSHNsRGxTQWN1RzZQb3RaZFlVNWlSUHI?oc=5) |
| Reuters | Obesity battle heats up again as Novo claws way back into race with Lilly | 2026-08-05 16:52 | [Source Link](https://news.google.com/rss/articles/CBMiwAFBVV95cUxQOFdYMERBcjBacXRBYmZhUllQVm05U2JzVDU5dGNveXE0dk10MmxSNWl3R0J4OVNmQlN2SjdtaGhSYXhfd3gtLVlTUkJ0NEFZRVJTMkFLTTB3TUVPaEpxdVI2bWMzaWtjbXhHczNCOXlwZTBvdUhVMHpQWDY5NXR6eU92SmN1dWw5YU8xTy1tb255TjR4ek1RMzJMUTdPbHRHQ3pwblRkbndQbUJCUWNZbUMyc1ZOZ0JKdy1wbkVDREM?oc=5) |
| Endpoints News | Novo vs. Lilly: Q2’s cardiometabolic grudge match | 2026-08-05 16:52 | [Source Link](https://news.google.com/rss/articles/CBMiekFVX3lxTFBpelhadEZieDEtTEZkUWxVaGt3VDRSWC15Y0pIRGwxODhqR3BrVm9ZU0hTeEF2VkZBel9HeHJCdzNZYktOTG1penhRem1iNURxX3ItRVZGWVNEbHBIMzFBTUVfNTIzOTJ4NEZfaWllVExUNTZ2MjBoS3p3?oc=5) |
| BioPharma Dive | Lilly climbs, Novo falls as obesity drug battle intensifies | 2026-08-05 16:52 | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxOR0U2VVNuYXY0X0tlWXlUZzNBRDlhN1V2SUR6U2hUYlVLLTRSZmpPeVJORzd2XzdkX0NSQi1Tekh6QkpZUDBIZ0lHVC1OdUhuQUpVeFdoQTJTMko1b1VjaG01WGVuQjljS0s1Qllid3QxNzNSYXpBWjVXOXNwaFZOSmxlVTV3UTNmVGhkcjJ0TlNSdUlZQUdXSUxlbnJqZ3BP?oc=5) |
| The Economist | Novo takes another shot at Lilly | 2026-08-05 16:52 | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQZG4za2JxY3NyLW5PMUZwTVBfQ1owRGpHV2ZVV2xZYzBjYXlzWF9sWkRHdUR0Q2gtN2JkRGViajNGVFVkdnkyaWpJQWpTV2NCZWRoNXJ6T2xfejVEcFduamVoR1JDTnpXMXBxWjVGUWZjMmI4RmQwbEdKbHgwVWtiZTV0SUQyZWNud1RpS2MweWNtejRYQlZn?oc=5) |
| MarketWatch | How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy? | 2026-08-05 16:52 | [Source Link](https://news.google.com/rss/articles/CBMi-wFBVV95cUxOSmcza242U0V3Tmw5SndjbmZCZnJVbjRxM3hoV2YtMjAzX1NQdmh6dGt5WXVpTFZvaFpTUGNQdnNXOXpXc0lkMk40M19DczY2czRRaHZQTWhuNnBUSFNvamVCTVUwT0lFMEFWbjJCREowVDhLTS00b0hTVXJEd3JkM1VkSm5mVFFBWS1vU2hIMlJnbEZVZ1BxZ1g0N0RPWldCaVFjVDZEeF8tT1dBNDA2YklkUE1sUy1sWnJxRlpNTmtGU1ZNc2owT3VHeDlrbGdZSWJNYVU3M05YNjhoVlZtT0IyckVzeTlXZ0xPTVVGZVlvMGJGOE5aSXdvVQ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-05/how-ozempic-maker-novo-nordisk-blew-its-lead-in-glp-1-weight-loss-drugs-can*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*